David C Habiger

Director David C Habiger purchased 4,450 shares at Boston Scientific for $251,098.10 across two days, raising holdings +47.2%.

David C Habiger, a Director at Boston Scientific, executed two separate purchases totaling 4,450 shares for $251,098.10 on 2026-05-19 and 2026-05-20 at prices of $56.95 and $55.92 respectively, with a blended average of $56.43. This transaction increased his holdings from 9,428 shares to 13,878 shares, representing a +47.2% increase in his position. The current stock price of $57.15 is -47.8% from the 52-week high of $109.50 and down -23.4% over the past 90 days, placing this purchase within a period of significant price decline. Across his cross-ticker trade history, Habiger's prior six open-market buys show an average 90-day return of +6.2% with a 33.33% win rate, providing limited historical precedent for assessing whether this particular purchase will prove well-positioned.

Reddit Director Habiger buys 780 RDDT shares at $126.07 after two consecutive purchases on 2025-03-12; stock down 44.2% from 52-week high.

David C. Habiger, a director of Reddit, Inc., purchased 780 shares at $126.07 on 2025-03-13, the third consecutive buy within two days (following two purchases on 2025-03-12). This brings his total holdings to 31,588 shares. The timing occurs against a backdrop of significant recent price weakness: the stock is -44.2% from its 52-week high and has declined -36.1% over the past 30 days and -25.6% over 90 days. Habiger's prior buy at this ticker (2024-03-25) delivered a +68.5% return over 90 days, demonstrating that his previous accumulation was well-timed as the stock recovered. The current backdrop of sharp recent declines following such a steep drawdown from peak valuations creates a factual context for evaluating this series of purchases, though the outcome remains unknown pending future price movement.

Director David C Habiger buys 774 shares of Reddit ($100.9K) at $130.36 amid 43% decline from 52-week high

Habiger executed 2 separate purchases totaling 774 shares for $100,894.77 at prices of $129.71 and $131.00 on 2025-03-12, increasing his holdings by +2.6% to 30,808 shares. The purchases occurred while RDDT trades at $128.21, down 43.1% from its 52-week high of $225.23 and down 40.8% over the prior 30 days, indicating substantial recent weakness. His prior trade at this ticker (2024-03-25 buy) generated a 90-day return of +68.5%, demonstrating effective prior timing at Reddit specifically. The company reported revenue of $348,351,000.00 ($348.4M) with net income of $29,853,000.00 ($29.9M) in the latest quarter and annual revenue growth of +61.7%, though it was unprofitable over the most recent full fiscal year. This director-level purchase into a steep drawdown from peak valuations provides a concrete signal of insider capital deployment during a period of acute price depreciation.

Director David C. Habiger bought 5,775 shares of Xperi (XPER) at $8.60 on 2024-08-22; part of 2-insider cluster buy pattern.

Habiger purchased 5,775 shares worth $49,685.21 at $8.60, increasing holdings by 8.5% to 73,980 shares. The purchase occurred as part of a cluster pattern with 2 other insiders buying within the past 14 days, signaling coordinated interest from the leadership group. Xperi trades at $8.81 currently, down 27.3% from its 52-week high of $12.12, and the company is unprofitable with a net income of -$30,299,000 in the latest quarter against $119,591,000 in revenue. The timing context shows Habiger executed a second purchase on consecutive days (prior buy on 2024-08-21), and his cross-ticker track record shows 100% win rate over 90 days with average 90-day return of +68.5% across 2 prior buys, though those outcomes are not yet measurable at this ticker.

Director Habiger buys 5,750 shares at $8.68 on 2024-08-21, increasing stake to 68,205 shares. Cluster buy pattern: 2 other insiders bought within past 14 days.

Director David C Habiger purchased 5,750 shares at $8.68, bringing his total holdings to 68,205 shares—a +9.2% increase in his position. The transaction coincides with a cluster pattern: 2 other insiders also bought XPER shares within the past 14 days, suggesting coordinated confidence among multiple board/management members. At current price $8.71, the purchase sits near cost, but the stock trades -28.1% from its 52-week high of $12.12, though it has rebounded +15.2% over the past 30 days. The fundamental backdrop is challenging: the company reported a $-30.3M net loss in its latest quarter against $119.6M revenue, and remains unprofitable on a full-year basis. The timing and multi-insider nature of these purchases merit monitoring against near-term operational improvements or strategic catalysts.